 |
인쇄하기
취소
|
JW Pharma unveils Actemra
JW Pharmaceutical said Thursday it has started selling Actemra (tocilizumab) here, giving patients with rheumatoid arthritis (RA) access to the new antibody medication.
Actemra is an immunosuppressive drug, mainly for the treatment of RA and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R...
Actemra is an immunosuppressive drug, mainly for the treatment of RA and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.